{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:04:03Z","timestamp":1783029843729,"version":"3.54.6"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease characterized by rapid progression and high mortality. Glucocorticoids (GCs) can be used as anti-inflammatory agents for SFTS, but no standardized protocols have been proposed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 901 patients with SFTS diagnosed at two hospitals between July 2017 and October 2023 were included in this retrospective cohort study. Univariate and multivariate logistic regression were performed along with LASSO regression to identify independent risk factors of fatal outcomes and further develop mortality prediction model. A nomogram was used to visualize the predictive model. ROC curves, calibration curves, and DCA curves were conducted to assess model accuracy and clinical applicability. The efficacy of GC was assessed using survival analyses, and further subgroup analyses of the effects of different GC regimens on fatal outcomes and hospital-acquired infections (HAI) were performed. Propensity score matching (PSM) analyses were conducted to control confounding factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Older age (age &amp;gt; 69 years), consciousness disturbance, decreased monocyte counts, prolonged activated partial thromboplastin time (APTT), and high viral load were identified as strong predictors of fatal outcomes in patients with SFTS. Patients were classified into mild and severe groups according to risk scores calculated by the nomogram (cut-off value = 121.43). Survival analyses showed that GCs treatment may reduce the mortality in severe patients (p = 0.004). Further subgroup analyses indicated that relatively high doses and early treatment with GCs may increase mortality in SFTS patients [OR = 2.292 (1.071, 5.066); OR = 3.693 (1.710, 8.345) respectively]. GCs treatment was associated with an elevated risk of HAI in patients both with mild and severe SFTS (p = 0.024; p = 0.015, respectively). Initiation of GCs therapy at a low level of aspartate aminotransferase (AST &amp;lt; 189.75 U\/L) reduced the mortality before and after PSM (p&amp;lt;0.001; p = 0.004, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A new nomogram based on five independent risk factors effectively predicts the prognosis of SFTS. Severe patients and those with low AST levels might benefit from GCs therapy while early and relatively high doses of GCs therapy should be used with caution.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1531880","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T05:27:23Z","timestamp":1746682043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Fatal risk factors and the efficacy of glucocorticoid therapy in severe fever with thrombocytopenia syndrome: a multicenter retrospective cohort study"],"prefix":"10.3389","volume":"15","author":[{"given":"Fang","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilihumaer","family":"Zhayier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cmet.2021.01.002","article-title":"The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19","volume":"33","author":"Cai","year":"2021","journal-title":"Cell Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3760\/cma.j.issn.1674-2397.2022.04.003","article-title":"Expert consensus on diagnosis and treatment of severe fever with thrombocytopenia syndrome","volume":"15","author":"Chen","year":"2022","journal-title":"Chin. J. Clin. Infect. Diseases"},{"key":"B3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3760\/cma.j.cn311365-20221017-00425","article-title":"Consensus on the diagnosis and treatment of severe fever with thrombocytopenia syndrome","volume":"40","year":"2022","journal-title":"Chin. J. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"20587384211063976","DOI":"10.1177\/20587384211063976","article-title":"Systemic corticosteroids for management of COVID-19: Saving lives or causing harm","volume":"35","author":"FakhriRavari","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.1002\/jmv.v94.12","article-title":"Coinfections in hospitalized patients with severe fever with thrombocytopenia syndrome: A retrospective study","volume":"94","author":"Ge","year":"2022","journal-title":"J. Med. Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.12659\/MSM.906250","article-title":"Dexamethasone stimulates hepatitis B virus (HBV) replication through autophagy","volume":"24","author":"He","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1002\/jmv.26877","article-title":"Changes in peripheral blood cytokines in patients with severe fever with thrombocytopenia syndrome","volume":"93","author":"He","year":"2021","journal-title":"J. Med. Virol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005909","article-title":"A scoring model for predicting prognosis of patients with severe fever with thrombocytopenia syndrome","volume":"11","author":"Jia","year":"2017","journal-title":"PloS Neglected Trop. Diseases"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009128","article-title":"Effects of steroid therapy in patients with severe fever with Thrombocytopenia syndrome: A multicenter clinical cohort study","volume":"15","author":"Jung","year":"2021","journal-title":"PloS Negl. Trop. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1186\/s12879-017-2858-y","article-title":"The impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study","volume":"17","author":"Katsurada","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/v13050785","article-title":"Corticosteroids may have negative effects on the management of patients with severe fever with thrombocytopenia syndrome: A case\u2013control study","volume":"13","author":"Kawaguchi","year":"2021","journal-title":"Viruses"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3390\/microorganisms11092309","article-title":"Emerging tick-borne dabie bandavirus: virology, epidemiology, and prevention","volume":"11","author":"Kim","year":"2023","journal-title":"Microorganisms"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study","volume":"18","author":"Li","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"112288","DOI":"10.1016\/j.intimp.2024.112288","article-title":"Development and validation of the PLNA score to predict cytokine storm in acute-phase SFTS patients: A single-center cohort study","volume":"136","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jmii.2024.02.002","article-title":"Effect of early dexamethasone on outcomes of COVID-19: A quasi-experimental study using propensity score matching","volume":"57","author":"Liu","year":"2024","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3760\/cma.j.issn.1674-2397.2011.04.001","article-title":"Guideline for prevention and treatment of severe fever with thrombocytopenia syndrome (2010 version)","volume":"4","year":"2011","journal-title":"Chin. J. Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jiac.2017.11.004","article-title":"Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome","volume":"24","author":"Nakamura","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijid.2015.12.009","article-title":"Decreased monocyte subsets and TLR4-mediated functions in patients with acute severe fever with thrombocytopenia syndrome (SFTS)","volume":"43","author":"Peng","year":"2016","journal-title":"Int. J. Infect. Diseases"},{"key":"B19","doi-asserted-by":"publisher","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12883-024-03664-6","article-title":"Severe fever with thrombocytopenia syndrome with central nervous system symptom onset: a case report and literature review","volume":"24","author":"Shan","year":"2024","journal-title":"BMC Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(20)30361-5","article-title":"On the use of corticosteroids for 2019-nCoV pneumonia","volume":"395","author":"Shang","year":"2020","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255033","article-title":"Application of a decision tree model in the early identification of severe patients with severe fever with thrombocytopenia syndrome","volume":"16","author":"Wang","year":"2021","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010489","article-title":"Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis","volume":"16","author":"Wang","year":"2022","journal-title":"PloS Negl. Trop. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"106481","DOI":"10.1016\/j.actatropica.2022.106481","article-title":"Clinical symptoms associated with fatality of severe fever with thrombocytopenia syndrome: A systematic review and meta-analysis","volume":"232","author":"Wang","year":"2022","journal-title":"Acta Trop."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29626","article-title":"Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome","volume":"96","author":"Wang","year":"2024","journal-title":"J. Med. Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijid.2023.03.015","article-title":"Clinical efficacy of low-dose glucocorticoid therapy for critically ill patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study","volume":"130","author":"Wang","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.7883\/yoken.JJID.2021.716","article-title":"Scoring model for predicting the occurrence of severe illness in hospitalized patients with severe fever with thrombocytopenia syndrome","volume":"75","author":"Wei","year":"2022","journal-title":"Jpn. J. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.907888","article-title":"NLR, A convenient early-warning biomarker of fatal outcome in patients with severe fever with thrombocytopenia syndrome","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011158","article-title":"A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study","volume":"17","author":"Xia","year":"2023","journal-title":"PloS Neglected Trop. Diseases"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ijid.2022.07.001","article-title":"Effects of corticosteroid treatment in patients with severe fever with thrombocytopenia syndrome: A single-center retrospective cohort study","volume":"122","author":"Xiong","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12879-021-06627-1","article-title":"Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis\/encephalopathy: a retrospective study","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1186\/s12879-024-09898-6","article-title":"Establishment and validation of a clinical risk scoring model to predict fatal risk in SFTS hospitalized patients","volume":"24","author":"Zhong","year":"2024","journal-title":"BMC Infect. Diseases"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1531880\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T05:27:26Z","timestamp":1746682046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1531880\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":33,"alternative-id":["10.3389\/fcimb.2025.1531880"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1531880","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"article-number":"1531880"}}